<DOC>
	<DOC>NCT00259636</DOC>
	<brief_summary>Patients with fibromyalgia &amp; migraine are randomized to receive zonisamide or placebo.</brief_summary>
	<brief_title>Zonisamide for Fibromyalgia &amp; Migraine</brief_title>
	<detailed_description>Study was not conducted due to logistical problems</detailed_description>
	<mesh_term>Migraine Disorders</mesh_term>
	<mesh_term>Fibromyalgia</mesh_term>
	<mesh_term>Myofascial Pain Syndromes</mesh_term>
	<mesh_term>Zonisamide</mesh_term>
	<criteria>1865 with fibromyalgia &amp; migraine allergy sulfa, liver or kidney disease, pregnant or not using contraception</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>May 2011</verification_date>
</DOC>